HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Valisure Alerts US FDA To Benzene In Dry Shampoos, Says Any Detected Level Could Be ‘Unacceptable’

Executive Summary

Valisure found 70% of 148 tested dry shampoo batches contained ‘quantifiable’ benzene. The US FDA advises a strict 2ppm limit when benzene’s use is unavoidable to produce a drug product with a “significant therapeutic advance.” In dry shampoos, “any significant detection of benzene could be deemed unacceptable,” Valisure suggests in its 31 October citizen petition to the agency.

You may also be interested in...



Unilever Recalls More Personal-Care Products That May Contain Benzene

The firm has instructed retailers to remove, and consumers not to use, selected lots of dry shampoo aerosol products from Dove, Nexxus, Suave, TIGI and TRESemme. The voluntary action follows Unilever’s recall of Suave aerosol antiperspirants in March, also due to potential benzene contamination.

Benzene Suits Against US Personal-Care Firms Appear Headed In One Direction: Settlement

The latest in litigation against Unilever, P&G, Beiersdorf and J&J alleging violations for selling personal-care products contaminated with benzene.

Unilever Recalls Benzene-Tainted Antiperspirants, Cites Propellant

Samples of two Suave 24-Hour Protection Aerosol Antiperspirants tested positive for “slightly elevated levels of benzene,” leading Unilever to recall all lots of the products that remain in circulation after the line’s discontinuation “for business reasons” in October 2021.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel